JBC Avanti Polar Lipids

HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Stargell, L. A.
Right arrow Articles by Struhl, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Stargell, L. A.
Right arrow Articles by Struhl, K.
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati  
What's this?

J Biol Chem, Vol. 275, Issue 17, 12374-12380, April 28, 2000


TFIIA Has Activator-dependent and Core Promoter Functions in Vivo*,

Laurie A. StargellDagger , Zarmik Moqtaderi§, David R. Dorris§, Ryan C. OggDagger , and Kevin Struhl§

From the Dagger  Department of Biochemistry and Molecular Biology, Colorado State University, Fort Collins, Colorado 80523 and the § Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, Boston, Massachusetts 02115

    ABSTRACT
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The physiological role of TFIIA was investigated by analyzing transcription in a yeast strain that contains a TATA-binding protein (TBP) mutant (N2-1) defective for interacting with TFIIA. In cells containing N2-1, transcription from a set of artificial his3 promoters dependent on different activators is generally reduced by a similar extent, indicating that TFIIA function is largely nonselective for activators. In addition, TATA element utilization, a core promoter function, is altered at his3 promoters dependent on weak activators. Genomic expression analysis reveals that 3% of the genes are preferentially affected by a factor of 4 or more. Chimeras of affected promoters indicate that the sensitivity to the TFIIA-TBP interaction can map either to the upstream or core promoter region. Unlike wild-type TBP or TFIIA, the N2-1 derivative does not activate transcription when artificially recruited to the promoter via a heterologous DNA binding domain, indicating that TFIIA is important for transcription even in the absence of an activation domain. Taken together, these results suggest that TFIIA plays an important role in both activator-dependent and core promoter functions in vivo. Further, they suggest that TFIIA function may not be strictly related to the recruitment of TBP to promoters but may also involve a step after TBP recruitment.

    INTRODUCTION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Initiation of RNA polymerase (pol)1 II transcription requires the assembly of a large complex of proteins that must interact at the promoter in a productive manner (1, 2). Formation of this complex is accelerated by activators that bind to the promoter and aid in recruitment of the components in the complex. The first step in promoter recognition is binding of TFIID to the TATA element. TFIID is a multiprotein complex containing TATA-binding protein (TBP) and TBP-associated factors (3). TFIIA stabilizes the TBP-TATA interaction (4-7) by interacting directly with the TBP and DNA flanking the TATA element (8, 9). TFIIA also counteracts several negative regulators of transcription that specifically target TBP. It inhibits the abilities of Mot1 and NC2 to dissociate TBP from the TATA element (10-13), and it blocks the inhibition of TBP binding to the TATA element by the N-terminal domain of TBP-associated factor 130 (14). Thus, there are several mechanisms by which TFIIA functions at core promoters in vitro.

Although TFIIA is not required for in vitro transcription using highly purified components, activated transcription is often stimulated by TFIIA. This is in accord with the observations that TFIIA can interact directly with activation domains in vitro (15-17) and that TFIIA is required for activator-dependent stabilization of the TFIID·TATA complex (16, 18-20). A simple model is that the activator-dependent TFIID·TFIIA complex is formed rapidly and stably on the TATA element, thereby serving as an efficient scaffold for the remainder of the initiation complex. Alternatively, TFIIA could act as a coactivator, conveying information between the activator and TBP. In this regard, in vitro cross-linking of an activator to TBP bound at a promoter is inhibited by TFIIA (21), suggesting that TFIIA is positioned between the activator and TBP. However, other biochemical experiments suggest that simple recruitment of the TFIID·TFIIA complex is not sufficient for activated transcription (22, 23). TFIIA may alter the conformation of TFIID such that either TFIID or the TFIIA·TFIID complex is a target for the remainder of the initiation machinery. It should be noted that the functional interaction between an activator and TFIIA need not be direct, and biochemical studies have identified coactivator proteins that interact with the activator and TFIIA (24). The physiological relevance of these observations and implied mechanisms remains to be established.

Several studies have addressed the role of TFIIA in vivo, but the results do not establish whether the functions of TFIIA in vivo are related to the activator, the core promoter, or both. Previously, we showed that a yeast TBP mutant (termed N2-1) defective for interacting with TFIIA impairs the response to acidic activators but does not generally affect pol II transcription (25). However, human TBP mutants severely defective for interacting with TFIIA are generally incompetent for transcription in transiently transfected mammalian cells (26). On the other hand, mutants of the Toa2 subunit of yeast TFIIA that weaken TFIIA-TBP·TATA complex formation confer selective transcriptional effects (27). Interpretation of these results is complicated because the various mutations might differentially affect the quality of the TFIIA-TBP interaction and because potential functions of TFIIA that are unrelated to interactions with TBP are not addressed. In complementary experiments, reduction of intracellular TFIIA levels caused a broad, but quantitatively modest, effect on transcription (7), but these results were limited by the partial nature of the TFIIA depletion and the lack of experiments involving activator-dependent transcription.

In this report, we extend our analysis of the N2-1 derivative of TBP by systematically examining its ability to respond to a large number of activators, by determining the regions of promoters that are responsible for altered transcription in the N2-1 strain, and by performing artificial recruitment experiments. Our results indicate that TFIIA plays an important role in both activator-dependent and core promoter functions in vivo, and they suggest that TFIIA functions, at least in part, in a step after TBP is recruited to the promoter.

    EXPERIMENTAL PROCEDURES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Analysis of his3 Promoter Derivatives-- To analyze transcriptional stimulation by different yeast activators, we started with a set of 13 strains described previously (28) that contain derivatives of the his3 promoter in which the natural enhancer region located upstream of the noncanonical (TC) and canonical (TR) his3 TATA elements is replaced with a specific activator binding site. After transformation of these 13 strains with a URA3 centromeric plasmid expressing wild-type TBP, the chromosomal TBP locus was replaced by a derivative in which the TBP protein coding sequence was replaced by the LEU2 gene. Finally, derivatives of these strains expressing wild-type TBP or the N2-1 derivative as the sole source of TBP (on TRP1 centromeric plasmids) were generated by plasmid shuffling. To analyze the ability of TBP and the N2-1 derivative to mediate the response to the various activators, cells were grown under appropriate conditions for the various activators, exactly as described previously (28). Levels of his3 transcription were determined by quantitative S1 analyses using hybridization reactions containing 20-40 µg of RNA and his3 and ded1 32P-labeled oligonucleotide probes as described previously (29).

Expression Analysis Using Genome Microarrays-- Yeast strains MMY101 and MMY102 (generated and kindly provided by Mario Mencia) were derived from ZMY117 (30) by LEU2 disruption of the genomic copy of TBP in the presence of wild-type TBP on a URA3 centromeric plasmid. TRP1 centromeric plasmids expressing wild-type TBP (for MMY101) or N2-1 (for MMY102) were introduced into this background by plasmid shuffling. Cells of each strain were cultured in synthetic medium at 30 °C to an A600 of 1, collected by centrifugation, and frozen in liquid nitrogen. Total cellular RNA was isolated by hot acid phenol extraction (29), and poly(A)-containing RNA was purified using Qiagen oligotex resin. Oligo(dT)-primed double-stranded cDNA was derived from this poly(A)-containing RNA, and 1 µg of the product was transcribed in vitro to generate internally biotin-labeled complementary RNA (31). The biotin-labeled RNA probes were fragmented, hybridized to half a set of Affymetrix yeast gene chip arrays (chips C and D, representing ~3200 open reading frames from chromosomes IX to XVI), fluorescently labeled, and analyzed on a Molecular Dynamics confocal scanner (31).

The results for the two strains were analyzed and compared using Affymetrix GeneChip software. For the comparison of expression results from the two strains, the data were normalized by two different methods: in the first, the overall hybridization intensity of the N2-1 sample was set equal to that of the wild-type sample for a given chip; and in the second, the data were normalized to set the hybridization intensities of both samples to the actin open reading frame (present on both C and D chips) at parity. The two methods of normalization yielded similar results, although there were minor variations in the fold change, and thus the rank order, of the open reading frames exhibiting changed expression. The genome microarray results for several representative RNAs were confirmed by quantitative S1 nuclease protection assays.

Transcriptional Analyses of Promoter Chimeras-- Based on the results of genome-wide analysis of transcription in the N2-1 strain, four genes were selected for analysis of their promoter sequences: CTR1 and PUT1, which are down-regulated in the N2-1 background, and ERG3 and CYC1, which are up-regulated in the N2-1 strain. All promoter fragments were produced by polymerase chain reaction using oligonucleotide primers that contain a restriction site at the 5'-end of the primer (an artificial BamHI site, which adds 6 base pairs to each promoter between the upstream and core promoter regions). Upstream promoter fragments are 750 base pairs in length, and the core promoter regions span from the distal end of the TATA box to the +7 site relative to the A of the start codon. The hybrid promoter constructs were cloned in frame with the gene encoding a modified version of green fluorescent protein (GFP, a gift from Pam Silver). The resulting chimeras were linearized with EcoRV and integrated at the ura3-52 locus of the TBP or N2-1 strains used for the genome microarray analysis. Quantitative S1 nuclease protection assays were performed as described (29) on RNA harvested from each strain. The sequence of the 55 base GFP probe is CCGTATGTTGCATCACCTTCACCCTCTCCACTGACAGAAAATTTGTGCCCTAATT, and S1 nuclease digestion of the hybrid between yeast RNA and this probe yields a product of 50 bases.

Artificial Recruitment Experiments-- LexA fusion constructs were tested in strain FT4, which contains a LexA operator 45 base pairs upstream of the his3 TATA element and structural gene (32). To generate molecules expressing LexA-TBP derivatives, the region encoding Cyc8 of YCp91-LexA-CYC8 (32) was replaced with the structural gene of wild-type TBP and the N2-1 derivative. The resulting molecule contains a 1.5-kilobase fragment of the ADH promoter driving expression of a hybrid protein consisting of the 202 amino acid coding sequence for LexA, the HA1 epitope, the SV40 nuclear localization signal, and the TBP derivative. YCp22 (the TRP1 vector) and molecules expressing LexA and the LexA-TBP derivatives were transformed into strain FT4, and his3 expression was monitored by spotting 104 cells on plates lacking histidine, containing either 0 or 20 mM aminotriazole, a competitive inhibitor of his3. LexA-TBP fusions were detected by immunoblot analyses of 100 µg of whole cell extracts using a polyclonal antibody to LexA and chemiluminescent detection.

Gal4 fusion constructs were tested in the strain MAV103, which contains the Gal4 UAS fused to the his3 TATA element and structural gene (33). Polymerase chain reaction was used to amplify the open reading frames of Toa1 and TBP, and these were cloned into pPC97, which contains the Gal4 DNA binding domain (residues 1-147) on a CEN, TRP1-marked plasmid (33). Molecules expressing these Gal4 derivatives were transformed into strain MAV103, and his3 expression was monitored by spotting 104 cells on plates lacking histidine, containing either 0 or 20 mM aminotriazole.

    RESULTS
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

The TFIIA-TBP Interaction Is Important, but Largely Nonselective, for Activators to Stimulate Transcription from the his3 Promoter-- In yeast and other eukaryotic cells, core promoters containing TATA and initiator elements are essentially inactive, indicating that transcription of essentially all genes requires activator proteins (34, 35). Previously, we showed that the N2-1 derivative of TBP was defective for transcription of genes responding to three different acidic activators, Gal4, Gcn4, and Ace1, and was defective in vitro for interaction with TFIIA (25). The growth and transcriptional phenotypes conferred by N2-1, but not by other TBP mutants, were suppressed by fusion to the Toa2 subunit of TFIIA, demonstrating that the defective TFIIA-TBP interaction is responsible for the phenotypes in vivo (25, 36). Although it is impossible to exclude the possibility that the N2-1 derivative might have other defects aside from its inability to interact with TFIIA, such additional defects do not account for the growth and transcriptional phenotypes. Interestingly, transcription of a number of other genes appeared unaffected in the N2-1 strain. This suggests that activators responsible for transcription of the unaffected genes should function normally in the N2-1 strain.

To test this hypothesis, we analyzed the role of the TFIIA-TBP interaction in 13 strains, each of which possesses a binding site for a different activator located upstream of the his3 TATA and initiator elements (28). These sites include those recognized by acidic activators or by activators with unclassified activation domains, as well as a poly(dA·dT) element that stimulates transcription via its inherent effect on chromatin structure (37). Unexpectedly, in almost all cases, his3 transcription is lower in the N2-1 strain than in the corresponding strain expressing wild-type TBP (Fig. 1). In the exceptional case of the activator Ppr1, transcriptional output is unaffected or slightly enhanced in the N2-1 strain. Thus, most of the activators tested are unable to support maximal levels of his3 transcription in the N2-1 strain. Interestingly, the transcriptional defect is quantitatively similar (2-3-fold) in essentially all cases examined, indicating that the TFIIA-TBP interaction is largely nonselective for activator function.


View larger version (33K):
[in this window]
[in a new window]
 
Fig. 1.   The TFIIA-TBP interaction is important, but largely nonselective, for activators to stimulate transcription from the his3 promoter. Stimulation of transcription by various yeast activators in strains containing either wild-type TBP (odd numbered lanes) or the TFIIA-defective N2-1 allele (even numbered lanes). RNA from strains containing HIS3 promoters with binding sites for the indicated transcription factors or strains that lack a binding site (none) were subjected to quantitative S1 analysis; the positions of the his3 (+1 and +13) and ded1 transcripts are indicated. As the strengths of the activators vary, the three panels correspond to different exposures.

The TFIIA-TBP Interaction Is Important for his3 TATA Element Utilization-- The his3 promoter contains a noncanonical TATA-like element (TC) that is responsible for initiation at the +1 position and a consensus TATA element (TR) that is responsible for initiation at +13 (28, 38-40). In accord with previous results (28), strains containing wild-type TBP show a clear pattern of his3 TATA utilization depending on the quality of activator (Fig. 1 and Table I). Specifically, as defined by the ratio of +13 to +1 transcripts, weak activators stimulate transcription predominantly through TC, moderate activators stimulate transcription equally from TC and TR, and strong activators preferentially stimulate transcription through TR. This pattern was interpreted in terms of functional saturation of TC (and other weak TATA elements) at low to moderate levels of transcriptional stimulation (28).

                              
View this table:
[in this window]
[in a new window]
 
Table I
Differential usage of the two qualitatively distinct TATA elements

As the wild-type pattern of his3 TATA utilization is governed specifically by the core promoter region and not the activator (28), factors that alter this pattern do so by affecting core promoter function (30, 41-43). In this regard, the corresponding strains containing the N2-1 derivative display a different pattern of his3 TATA element utilization (Table I). In promoters dependent on weak activators, a larger percentage of the total transcription is driven from TR, producing a +13 to +1 ratio of nearly 1 or greater. A similarly increased preference for TR and +13 initiation is also observed for moderate activators, including Ppr1. Importantly, increased utilization of TR in strains containing N2-1 is observed even though the overall level of transcription is lower; this contrasts with the situation in wild-type cells where increased TR utilization is associated with an overall increase in his3 transcription levels (28). Taken together, these results suggest that TC is saturating at a lower level of transcription in the N2-1 strain as compared with wild type strain and that noncanonical TATA elements depend on the TFIIA-TBP interaction to achieve maximal levels of transcription. Differential preference of his3 TATA elements is not observed for potent activators (Gcn4, Ace1, and Gal4), suggesting that a strong activator can bypass at least part of the defect associated with a defective TFIIA-TBP interaction. The observation that the N2-1 derivative alters the wild-type rules of his3 TATA element utilization provides evidence that TFIIA performs a function at core promoters.

A Defective TFIIA-TBP Interaction Delays the Induction of Gal4-dependent Activation-- The modest defect in Gal4-dependent activation (Fig. 1) appears to conflict with our previous observation (25) that the N2-1 derivative was completely unable to mediate activation by Gal4. This apparent discrepancy was resolved by analyzing the kinetics of Gal4-dependent activation of GAL1 transcription. The TBP-containing strain achieves maximal levels of activation by 30-60 min, with an increase in GAL1 RNA observed after only 10 min in galactose (Fig. 2A; data not shown). In contrast, the N2-1 strain requires 6 h for detectable induction and 12 h to reach maximum output. Although there is a substantial growth difference between the TBP and N2-1 strains (doubling times 85 min and 6 h, respectively), the slow induction of GAL1 transcription is not explained simply by the altered growth rates. For example, at a time corresponding to half a generation (45 min and 3 h, respectively), GAL1 transcription is maximal in the strain containing wild-type TBP, whereas it is not detectable in the N2-1 strain. In the previously published experiment, which involved a different strain background, the doubling time for the N2-1 strain was 10 h, galactose induction was performed for 18 h, and GAL1 transcription was not detected. However, when the original strain is cultured for longer times, a slight Gal4-dependent response is observed at 24 h, and a response corresponding to 20-30% of the wild-type level is observed at 72 h (Fig. 2B). Thus, in both the original and current strain backgrounds, the N2-1 derivative delays the induction of Gal4-dependent activation but only causes a mild (3-5 fold) defect in the maximal level of GAL1 transcription.


View larger version (78K):
[in this window]
[in a new window]
 
Fig. 2.   Kinetics of Gal4-dependent activation. A, RNA was harvested from strains grown from 0 to 24 h in 2% galactose. Strains (FT4 background) contained the Gal4 DNA binding element driving expression of the HIS3 gene with either wild-type (TBP) or the N2-1 allele. The positions of the his3 (+1 and +13) and ded1 transcripts are indicated. B, RNA was harvested galactose from strains (KY320 background) containing either wild-type (TBP) or the N2-1 allele that were grown in 2% galactose for 0 to 72 h. The positions of the gal1 and ded1 transcripts are indicated.

Effect of a Defective TFIIA-TBP Interaction on Genome-wide Expression Patterns-- To examine the global implications of an impaired TFIIA-TBP interaction, we compared the pattern of gene expression of N2-1 and wild-type cells using microarray technology (44). Analysis of ~3200 genes reveals that 42 (1.3%) are expressed at least 4-fold higher in the N2-1 strain than in the wild-type strain and that 47 (1.5%) are expressed at levels at least 4-fold lower in the N2-1 strain (Table II). If changes of at least 2-fold are considered, 9% of genes are expressed at higher levels in the N2-1 strain, and 8% are expressed at lower levels in the N2-1 strain relative to the strain containing wild-type TBP. This percentage of genes preferentially affected by at least 2-fold in the N2-1 strain is comparable to or higher than that caused by mutations in GCN5 (5% affected), SRB5 (16% affected), and SWI2 (6% affected) (45). With the exception of increased expression of several ribosomal protein genes in the N2-1 strain, we detected no obvious patterns in the genes with changed expression levels. The wide range and apparent unrelated nature of genes preferentially affected by the N2-1 mutation are consistent with the relative lack of activator specificity observed with the modified his3 promoters.

                              
View this table:
[in this window]
[in a new window]
 
Table II
Genes that exhibit altered levels of expression in the N2-1 strain

An important consideration in interpreting these genome-wide expression results is that equal amounts of wild-type and N2-1 mRNA samples were analyzed. For this reason, all changes caused by the defective TFIIA-TBP interaction (either positive or negative) are defined relative to the significant majority of "unaffected" genes. Overall changes in RNA levels, such as a possible broad reduction in the slowly growing N2-1 strain, are effectively normalized out and hence rendered imperceptible. Thus, we cannot distinguish whether the genes with changed RNA levels are indeed the only ones affected or whether they simply represent, within a globally changed background, an RNA population disproportionately sensitive (or abnormally insensitive) to a weakened TBP-TFIIA interaction. Finally, as the N2-1 strain is stable and viable, the transcriptional profile represents not just the primary effects of a sabotaged TBP-TFIIA interaction, but also all the secondary consequences that affect cell growth and perhaps even transcription by RNA polymerases I and III.

Sensitivity to the TFIIA-TBP Interaction Can Reside in Either the Upstream or the Core Promoter Region-- To localize the dependence on the TFIIA-TBP interaction to the upstream or core promoter region, chimeric promoters were created among four genes specifically affected in the N2-1 strain (Fig. 3). PUT1 and CTR1 expression levels are decreased in the N2-1 strain as compared with wild-type TBP, whereas ERG3 and CYC1 RNA levels are increased (Table II and Fig. 4). One part of each chimeric promoter was derived from a gene whose expression is increased in the N2-1 strain, and the other part was derived from a gene whose expression was decreased. A complete set of reciprocal chimeras and control promoters with upstream and core regions from the same gene, were fused to the GFP structural gene and analyzed for transcriptional activity in wild-type and N2-1 strains. It should be noted that, with the exception of CYC1, the promoters utilized in this experiment have not been subjected to detailed analysis; hence, boundaries between core and upstream regions have been defined by the position of the likely TATA element.


View larger version (34K):
[in this window]
[in a new window]
 
Fig. 3.   Generation of chimeric promoters derived from genes differentially affected by the TFIIA-TBP interaction. A, diagrams of the CYC1, ERG3, CTR1, and PUT1 promoters with the upstream regions (thick boxes), core regions (thin boxes), putative TATA elements (location defined with respect to the ATG codon at +1), and transcriptional initiation sites (arrows in cases where this information is known). The boundary between the upstream and core regions is an artificially generated BamHI site, which was used to generate the chimeric promoters. All chimeric promoters were fused to the GFP structural gene and analyzed by S1 analysis using a probe corresponding to residues +79 to +122. B, transcriptional properties of the chimeric promoters as determined from data in Fig. 4. For each chimera, the region that determines the differential response in the N2-1 strain is indicated. In the CTR1-ERG3 and ERG3-CTR1 chimeras, both elements contribute with the upstream region playing a predominant role in latter case.


View larger version (39K):
[in this window]
[in a new window]
 
Fig. 4.   Transcriptional analysis of chimeric promoters. RNAs from strains containing chimeric promoters with the indicated upstream and core promoter regions (see Fig. 3) were hybridized to completion with a mixture of oligonucleotide probes for GFP, DED1, and tryptophan tRNA, and the resulting products were treated with S1 nuclease. The three transcripts were analyzed on the same gel, but the autoradiograph was exposed for a longer time in the case of GFP.

For PUT1, decreased expression in the N2-1 strain clearly maps to the upstream region. Both chimeras containing the PUT1 upstream region show significantly decreased expression in the N2-1 strain, whereas both chimeras containing the PUT1 core region show increased transcription characteristic of the CYC1 and ERG3 genes. The transcriptional properties of these PUT1 chimeras also suggest that the CYC1 and ERG3 upstream regions are important for the differential response to N2-1.

In the case of ERG3 and CTR1, the upstream regions play the predominant role, but they do not completely account for the differential response to N2-1. Specifically, the CTR1 upstream-ERG3 core promoter chimera shows a decrease characteristic of CTR1, but the chimeric promoter is less affected than the natural promoter. Conversely, the reciprocal ERG3-CTR1 chimera behaves more similarly to ERG1 than to CTR1, but the chimeric promoter does not show increased expression in the N2-1 strain (it may even be very slightly reduced). Lastly, the core region of CYC1 clearly contributes to the increased transcription in the N2-1 strain, because the CTR1-CYC1 chimera behaves indistinguishably from the natural CYC1 gene. Taken together, these results indicate that the function of both the upstream region and the core promoter can be sensitive to a defect in the TFIIA-TBP interaction.

The Defective TFIIA-TBP Interaction Cannot Be Overcome by Artificial Recruitment of TBP to the Promoter-- When wild-type TBP is tethered to promoters via a DNA binding domain located upstream of a TATA element, transcriptional activation occurs in the absence of an activation domain (46-48). Under these artificial recruitment circumstances, interactions that require the activation domain are bypassed, and TBP and other general transcription factors can only perform core promoter functions. Conversely, LexA-TBP derivatives that fail to activate transcription upon artificial recruitment are defective in a core promoter function. By this criterion, the N2-1 derivative is defective in a core promoter function, because LexA-N2-1 does not activate transcription when artificially recruited to a promoter (Fig. 5A). LexA-N2-1 is expressed at a level equivalent to that of LexA-TBP (Fig. 5B), and it is capable of supporting cell growth (data not shown). These results indicate that the TFIIA-TBP interaction plays an important role in core promoter function in vivo.


View larger version (69K):
[in this window]
[in a new window]
 
Fig. 5.   Artificial recruitment assay of LexA-TBP and LexA-N2-1. A, strains containing LexA-TBP, LexA-N2-1, LexA, or vector and a promoter with a LexA operator 45 base pairs upstream of the his3 TATA element and structural gene were tested for growth on 20 mM aminotriazole (AT). Plates were photographed after 3 days growth at 30 °C. The degree of AT resistance is directly related to the level of his3 transcription. B, LexA-TBP and LexA-N2-1 proteins are produced at similar levels. Immunoblot analyses of 100 µg of whole cell extract from each of the indicated strains probed with anti-LexA antibody (a gift from R. Brent). The arrows indicate where the LexA-TBP fusions and LexA alone migrate.

Recruitment of TFIIA to a Promoter Efficiently Stimulates Transcription-- In addition to TBP, artificial recruitment of TBP-associated factors (49-51), TFIIB (50, 52), and various subunits of the pol II holoenzyme (53-56) results in transcriptional activation. To examine whether TFIIA stimulates transcription when artificially recruited to a promoter, we examined the activity of a hybrid protein comprising the Gal4 DNA binding domain and the Toa1 subunit of TFIIA. As shown in Fig. 6, Gal4-Toa1 stimulates expression of a Gal4-dependent promoter to a level comparable to that observed with Gal4-TBP. Although we have not excluded the possibility of a fortuitous activation surface on Toa1 (57), this result suggests that tethering TFIIA to a promoter bypasses the need for activator-mediated recruitment of the pol II machinery. Although this observation does not necessarily indicate that TFIIA is a target of natural activators, it suggests that a hypothetical activator-TFIIA interaction will contribute to the level of transcriptional activation in vivo.


View larger version (22K):
[in this window]
[in a new window]
 
Fig. 6.   Transcriptional activation by artificial recruitment of TFIIA. Strains expressing the Gal4 DNA binding domain (residues 1-147), Gal4-TBP, and Gal4-Toa1 and containing a promoter with the Gal4 enhancer fused to the his3 TATA element and structural gene were tested for growth on 20 mM aminotriazole (AT). The degree of AT resistance is directly related to the level of his3 transcription.


    DISCUSSION
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

Transcriptional Defects Conferred by the N2-1 Derivative of TBP Are Relatively Nonspecific for the Activator-- Our original studies of the N2-1 derivative indicated that transcription dependent on strong activators (Gcn4, Ace1, and Gal4) was severely defective, whereas constitutive expression from a broad range of pol II promoters was relatively unaffected (25). This led us to hypothesize that the N2-1 strain would be competent for the response to activators involved in constitutive transcription. In contrast to this expectation, analysis of his3 promoters driven by a variety of activators reveals that N2-1 confers reduced (2-3-fold) levels of transcription in nearly every case (except Ppr1).

Our results force a revision to our original interpretation of the N2-1 derivative as being specifically defective in the response to acidic activators. Instead, the transcriptional defects of the artificial his3 promoters are relatively nonspecific for the activator. In addition, microarray analysis indicates that the subset of genes preferentially affected in the N2-1 strain do not show a clear pattern suggestive of a response to specific activators. Finally, the relative lack of activator specificity is consistent with the observation that transcription of nearly all genes tested is reduced ~2-5-fold upon loss of TFIIA (7).

Why do TFIIA-depleted cells show a broad, but quantitatively modest, reduction in transcription (7), whereas N2-1 cells appear to display defects for a small subset of genes? One possibility is that the N2-1 derivative does not completely block the TFIIA-TBP interaction and hence confers a less severe effect than eliminating TFIIA. Alternatively, because TFIIA is present at normal levels in the N2-1 strain, it might be recruited to promoters by an alternative mechanism involving interactions with activators (15, 16), TBP-associated factors in the TFIID complex (58, 59), or TFIIE (60). Finally, the difference between N2-1 and TFIIA-depleted cells might be more apparent than real. A broad decrease in pol II transcription in N2-1 cells might be obscured (or normalized out) by the fact that equivalent amounts of RNA from wild-type and mutant cells are assayed even though the cells grow at different rates. Such a broad pol II defect could easily account for the slow growth of N2-1 strains, and slowly growing cells also have a reduced steady-state level of pol I and pol III transcription. In contrast, TFIIA-depleted cells are analyzed soon after the depletion, conditions in which indirect growth-dependent effects on pol I and pol III transcription should not be confounding, and the broad decrease in pol II transcription can be easily observed.

Role for TFIIA in Core Promoter Functions-- Basal transcription from a core promoter using purified factors is a concept defined in vitro. In vivo, core promoters typically have very low levels of transcription (34), probably because of the repressive effects of chromatin (35, 61, 62). As such, it is likely that transcription in vivo represents some form of activated transcription. Consequently, it is often difficult to determine whether an observed transcriptional defect in vivo reflects a core promoter function or an activator-specific function. For example, a mutated TATA element reduces the level of activator-dependent transcription even though the TATA element is clearly involved in a core promoter function.

Three lines of evidence demonstrate that TFIIA is important for core promoter function(s) in vivo. First, the N2-1 strain shows differential utilization of the his3 TATA elements, with TC (the nonconsensus TATA element) saturating at a lower level of transcription in comparison to the wild-type strain. This suggests that, relative to TR (the canonical TATA element), TC is a weaker element in the N2-1 strain than in the wild-type strain. As the rules of his3 TATA utilization are governed specifically by the core promoter region and not the activator (28), factors that alter these rules do so by affecting core promoter function (30, 41-43). Second, the N2-1 derivative does not stimulate transcription when artificially recruited to promoters. As artificial recruitment represents an experimental situation in which the normal activation process (i.e. dependent on activation domains) is completely bypassed, the defect of N2-1 must reflect a core promoter function. Third, analysis of chimeric promoters indicates that, in some cases, the core region can contribute to altered expression in the N2-1 strain.

Role for TFIIA in Activator-specific Functions-- There are two basic ways to interpret the observation that the defect in activator-dependent his3 transcription in the N2-1 strain is relatively nonspecific for the activator. In one interpretation, this defect may be because of the his3 core promoter rather than the specific activator. In this regard, a defective core promoter function such as a weakened TBP-TATA interaction can cause the appearance of a defect in the response to transcriptional activators (28, 63, 64). In the alternative explanation, TFIIA could perform a common, but not absolutely required, function that is related to activators. For example, TFIIA could be a common target of activators or it could stabilize/alter the conformation of the direct activator target. In this regard, our observation that Gal4-Toa1 activates transcription suggests that an activator-TFIIA contact will contribute to transcriptional activity in vivo. These two basic explanations are not mutually exclusive, and they also apply to the related observation that depletion of TFIIA causes a general, and quantitatively similar, reduction in pol II transcription, even though individual promoters differ markedly in their upstream regions and hence activator binding sites.

Despite the difficulties of distinguishing between core and activator-specific functions in many situations, our analysis of chimeric promoters provides strong evidence that TFIIA does perform a function that is related to activators. In most cases tested, altered expression because of the defective TFIIA-TBP interaction is associated with the upstream region, not the core promoter. Although we cannot exclude the possibility that the dependence on the upstream region of the chimeric promoters is indirect (i.e. by altered expression of genes encoding proteins that interact with these upstream regions), these results strongly suggest that TFIIA displays some degree of specificity with respect to activators. Thus, our analysis of the N2-1 derivatives provides evidence that TFIIA has both activator-specific and core promoter functions in vivo.

Evidence That TFIIA Has a Role after Recruitment of TBP to the TATA Element-- A large body of biochemical evidence suggests that TFIIA stabilizes the TBP-TATA element interaction and stimulates recruitment of TBP to promoters. Our observation that artificial recruitment of TFIIA (via the Toa1 subunit) results in transcriptional stimulation is consistent with a role of TFIIA in TBP recruitment, because transcriptional activity is highly correlated with increased TBP occupancy in vivo (65, 66). However, by analogy with other TBP mutants (36), the observation that artificial recruitment of N2-1 does not bypass the defect in the TFIIA interaction suggests a role for TFIIA in a post-recruitment step for transcription in vivo. These results do not exclude a role of TFIIA in recruitment of TBP but rather suggest an additional function(s) of TFIIA after binding the TATA element. In accord with such a post-recruitment role, there are TFIIA mutants that are normal for formation of a TBP·TFIIA·TATA complex but defective for activated transcription in vitro (67). This suggests that formation of the stable complex is not sufficient to achieve activated transcription and that TFIIA is unlikely to function solely as a bridging factor between the activators and the general machinery. Although the nature of this post-recruitment step is unknown, TFIIA can induce conformational changes in TFIID at the promoter (59, 68), and it can physically interact with TFIIE (60), which functions late in the transcription process (1, 2). Thus, it is likely that TFIIA plays multiple roles in the transcriptional process in vivo.

    ACKNOWLEDGEMENTS

We thank Chris Harrington, Mamatha Mahadev, Gene Tanimoto, and Lisa Wodicka for generous hospitality at Affymetrix and essential help in performing and interpreting the microarray analysis, George Church for access to computers to perform microarray data analysis, Mario Mencia for yeast strains and RNA preparation for the genome-wide analysis, and Roger Brent for LexA antibodies.

    FOOTNOTES

* This work was supported by Research Grants GM56884 (to L. A. S.) and GM30186 (to K. S.) from the National Institutes of Health.The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

The on-line version of this article (available at http://www.jbc.org) contains gene chip data.

To whom correspondence should be addressed. Tel.: (617) 432-2104; Fax: (617) 432-2529; E-mail: kevin@hms.harvard.edu.

    ABBREVIATIONS

The abbreviations used are: pol, polymerase; TBP, TATA-binding protein; GFP, green fluorescent protein.

    REFERENCES
TOP
ABSTRACT
INTRODUCTION
EXPERIMENTAL PROCEDURES
RESULTS
DISCUSSION
REFERENCES

1. Roeder, R. G. (1996) Trends Biochem. Sci. 21, 327-335[CrossRef][Medline] [Order article via Infotrieve]
2. Orphanides, G., Lagrange, T., and Reinberg, D. (1996) Genes Dev. 10, 2657-2683[Free Full Text]
3. Burley, S. K., and Roeder, R. G. (1996) Annu. Rev. Biochem. 65, 769-799[CrossRef][Medline] [Order article via Infotrieve]
4. Buratowski, S., Hahn, S., Guarente, L., and Sharp, P. A. (1989) Cell 56, 549-561[CrossRef][Medline] [Order article via Infotrieve]
5. Lee, D. K., Dejong, J., Hashimoto, S., Horikoshi, M., and Roeder, R. G. (1992) Mol. Cell. Biol. 12, 5189-5196[Abstract/Free Full Text]
6. Imbalzano, A. N., Zaret, K. S., and Kingston, R. E. (1994) J. Biol. Chem. 269, 8280-8286[Abstract/Free Full Text]
7. Kang, J. J., Auble, D. T., Ranish, J. A., and Hahn, S. (1995) Mol. Cell. Biol. 15, 1234-1243[Abstract]
8. Geiger, J. H., Hahn, S., Lee, S., and Sigler, P. B. (1996) Science 272, 830-836[Abstract]
9. Tan, S., Hunziker, Y., Sargent, D. F., and Richmond, T. J. (1996) Nature 381, 127-134[CrossRef][Medline] [Order article via Infotrieve]
10. Auble, D. T., Hansen, K. E., Mueller, C. G. F., Lane, W. S., Thorner, J., and Hahn, S. (1994) Genes Dev. 8, 1920-1934[Abstract/Free Full Text]
11. Goppelt, A., Stelzer, G., Lottspeich, F., and Meisterernst, M. (1996) EMBO J. 15, 3105-3116[Medline] [Order article via Infotrieve]
12. Mermelstein, F., Yeung, K., Cao, J., Inostroza, J. A., Erdjument-Bromage, H., Eagelson, K., Landsman, D., Levitt, P., Tempst, P., and Reinberg, D. (1996) Genes Dev. 10, 1033-1048[Abstract/Free Full Text]
13. Kim, J., Parvin, J. D., Shykind, B. M., and Sharp, P. A. (1996) J. Biol. Chem. 271, 18405-18412[Abstract/Free Full Text]
14. Kokubo, T., Swanson, M. J., Nishikawa, J. I., Hinnebusch, A. G., and Nakatani, Y. (1998) Mol. Cell. Biol. 18, 1003-1012[Abstract/Free Full Text]
15. Ozer, J., Moore, P. A., Bolden, A. H., Lee, A., Rosen, C. A., and Lieberman, P. M. (1994) Genes Dev. 8, 2324-2335[Abstract/Free Full Text]
16. Kobayashi, N., Boyer, T. G., and Berk, A. J. (1995) Mol. Cell. Biol. 15, 6465-6473[Abstract]
17. Clemens, K. E., Piras, G., Radonovich, M. F., Choi, K. S., Duvall, J. F., DeJong, J., Roeder, R., and Brady, J. N. (1996) Mol. Cell. Biol. 16, 4656-4664[Abstract]
18. Lieberman, P. M., and Berk, A. J. (1994) Genes Dev. 8, 995-1006[Abstract/Free Full Text]
19. Damania, B., Lieberman, P., and Alwine, J. C. (1998) Mol. Cell. Biol. 18, 3926-3935[Abstract/Free Full Text]
20. Ranish, J. A., Yudkovsky, N., and Hahn, S. (1999) Genes Dev. 13, 49-63[Abstract/Free Full Text]
21. Emili, A., and Ingles, C. J. (1995) J. Biol. Chem. 270, 13674-13680[Abstract/Free Full Text]
22. Shykind, B. M., Kim, J., and Sharp, P. A. (1995) Genes Dev. 9, 1354-1365[Abstract/Free Full Text]
23. Chi, T., and Carey, M. (1996) Genes Dev. 10, 2540-2550[Abstract/Free Full Text]
24. Ge, H., and Roeder, R. G. (1994) Cell 78, 513-523[CrossRef][Medline] [Order article via Infotrieve]
25. Stargell, L. A., and Struhl, K. (1995) Science 269, 75-78[Abstract/Free Full Text]
26. Bryant, G. O., Martel, L. S., Burley, S. K., and Berk, A. J. (1996) Genes Dev. 10, 2491-2504[Abstract/Free Full Text]
27. Ozer, J., Lezina, L. E., Ewing, J., Audi, S., and Lieberman, P. M. (1998) Mol. Cell. Biol. 18, 2559-2570[Abstract/Free Full Text]
28. Iyer, V., and Struhl, K. (1995) Mol. Cell. Biol. 15, 7059-7066[Abstract]
29. Iyer, V., and Struhl, K. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 5208-5212[Abstract/Free Full Text]
30. Moqtaderi, Z., Keaveney, M., and Struhl, K. (1998) Mol. Cell 2, 675-682[CrossRef][Medline] [Order article via Infotrieve]
31. Wodicka, L., Dong, H., Mittman, M., Ho, M. H., and Lockhart, D. J. (1997) Nature Biotech. 15, 1359-1367[CrossRef][Medline] [Order article via Infotrieve]
32. Tzamarias, D., and Struhl, K. (1994) Nature 369, 758-761[CrossRef][Medline] [Order article via Infotrieve]
33. Vidal, M., Brachmann, R. K., Fattaey, A., Harlow, E., and Boeke, J. D. (1996) Proc. Natl. Acad. Sci. U. S. A. 93, 10315-10320[Abstract/Free Full Text]
34. Struhl, K. (1989) Ann. Rev. Biochem. 58, 1051-1077[CrossRef][Medline] [Order article via Infotrieve]
35. Struhl, K. (1999) Cell 98, 1-4[CrossRef][Medline] [Order article via Infotrieve]
36. Stargell, L. A., and Struhl, K. (1996) Mol. Cell. Biol. 16, 4456-4464[Abstract]
37. Iyer, V., and Struhl, K. (1995) EMBO J. 14, 2570-2579[Medline] [Order article via Infotrieve]
38. Struhl, K. (1986) Mol. Cell. Biol. 6, 3847-3853[Abstract/Free Full Text]
39. Chen, W., and Struhl, K. (1988) Proc. Natl. Acad. Sci. U. S. A. 85, 2691-2695[Abstract/Free Full Text]
40. Mahadevan, S., and Struhl, K. (1990) Mol. Cell. Biol. 10, 4447-4455[Abstract/Free Full Text]
41. Collart, M. A., and Struhl, K. (1993) EMBO J. 12, 177-186[Medline] [Order article via Infotrieve]
42. Collart, M. A. (1996) Mol. Cell. Biol. 16, 6668-6676[Abstract]
43. Moqtaderi, Z., Bai, Y., Poon, D., Weil, P. A., and Struhl, K. (1996) Nature 382, 188-191
44. Lockhart, D. J., Dong, H., Byrne, M. C., Follettie, M. T., Gallo, M. V., Chee, M. S., Mittmann, M., Wang, C., Kobayashi, M., Horton, H., and Brown, E. L. (1996) Nature Biotechnol. 14, 1675-1680[CrossRef][Medline] [Order article via Infotrieve]
45. Holstege, F. C., Jennings, E. G., Wyrick, J. J., Lee, T. I., Hengartner, C. J., Green, M. R., Golub, T. R., Lander, E. S., and Young, R. A. (1998) Cell 95, 717-728[CrossRef][Medline] [Order article via Infotrieve]
46. Chatterjee, S., and Struhl, K. (1995) Nature 374, 820-822[CrossRef][Medline] [Order article via Infotrieve]
47. Klages, N., and Strubin, M. (1995) Nature 374, 822-823[CrossRef][Medline] [Order article via Infotrieve]
48. Xiao, H., Friesen, J. D., and Lis, J. T. (1995) Mol. Cell. Biol. 15, 5757-5761[Abstract]
49. Apone, L. M., Virbasius, C. A., Reese, J. C., and Green, M. R. (1996) Genes Dev. 10, 2368-2380[Abstract/Free Full Text]
50. Gonzalez-Couto, E., Klages, N., and Strubin, M. (1997) Proc. Natl. Acad. Sci. U. S. A. 94, 8036-8041[Abstract/Free Full Text]
51. Keaveney, M., and Struhl, K. (1998) Mol. Cell 1, 917-924[CrossRef][Medline] [Order article via Infotrieve]
52. Lee, M., and Struhl, K. (1997) Mol. Cell. Biol. 17, 1336-1345[Abstract]
53. Jiang, Y. W., and Stillman, D. J. (1992) Mol. Cell. Biol. 12, 4503-4514[Abstract/Free Full Text]
54. Barberis, A., Pearlberg, J., Simkovich, N., Farrell, S., Reinagel, P., Bamdad, C., Sigal, G., and Ptashne, M. (1995) Cell 81, 359-368[CrossRef][Medline] [Order article via Infotrieve]
55. Farrell, S., Simkovich, N., Wu, Y. B., Barberis, A., and Ptashne, M. (1996) Genes Dev. 10, 2359-2367[Abstract/Free Full Text]
56. Gaudreau, L., Keaveney, M., Nevado, J., Zaman, Z., Bryant, G. O., Struhl, K., and Ptashne, M. (1999) Proc. Natl. Acad. Sci. U. S. A. 96, 2668-2673[Abstract/Free Full Text]
57. Li, Y. F., Le Gourierrec, J., Torki, M., Kim, Y. J., Guerineau, F., and Zhou, D. X. (1999) Plant Mol. Biol. 39, 515-525[CrossRef][Medline] [Order article via Infotrieve]
58. Hansen, S. K., and Tjian, R. (1995) Cell 82, 565-575[CrossRef][Medline] [Order article via Infotrieve]
59. Emami, K. H., Jain, A., and Smale, S. T. (1997) Genes Dev. 11, 3007-3019[Abstract/Free Full Text]
60. Yokomori, K., Verrijzer, C. P., and Tjian, R. (1998) Proc. Natl. Acad. Sci. U. S. A. 95, 6722-6727[Abstract/Free Full Text]
61. Felsenfeld, G. (1992) Nature 355, 219-224[CrossRef][Medline] [Order article via Infotrieve]
62. Paranjape, S. M., Kamakaka, R. T., and Kadonaga, J. T. (1994) Ann. Rev. Biochem. 63, 265-297[CrossRef][Medline] [Order article via Infotrieve]
63. Arndt, K. M., Ricupero-Hovasse, S., and Winston, F. (1995) EMBO J. 14, 1490-1497[Medline] [Order article via Infotrieve]
64. Lee, M., and Struhl, K. (1995) Mol. Cell. Biol. 15, 5461-5469[Abstract]
65. Kuras, L., and Struhl, K. (1999) Nature 389, 609-612
66. Li, X.-L., Virbasius, A., Zhu, X., and Green, M. R. (1999) Nature 389, 605-609
67. Ozer, J., Bolden, A. H., and Lieberman, P. M. (1996) J. Biol. Chem. 271, 11182-11190[Abstract/Free Full Text]
68. Oelgeschlager, T., Chiang, C. M., and Roeder, R. G. (1996) Nature 382, 735-738[CrossRef][Medline] [Order article via Infotrieve]


Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?


This article has been cited by other articles:


Home page
Mol. Cell. Biol.Home page
H. Zhou, S. Spicuglia, J. J.-D. Hsieh, D. J. Mitsiou, T. Hoiby, G. J. C. Veenstra, S. J. Korsmeyer, and H. G. Stunnenberg
Uncleaved TFIIA Is a Substrate for Taspase 1 and Active in Transcription.
Mol. Cell. Biol., April 1, 2006; 26(7): 2728 - 2735.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
S. Gilfillan, G. Stelzer, E. Piaia, M. G. Hofmann, and M. Meisterernst
Efficient Binding of NC2{middle dot}TATA-binding Protein to DNA in the Absence of TATA
J. Biol. Chem., February 18, 2005; 280(7): 6222 - 6230.
[Abstract] [Full Text] [PDF]


Home page
Genes Dev.Home page
L. Warfield, J. A. Ranish, and S. Hahn
Positive and negative functions of the SAGA complex mediated through interaction of Spt8 with TBP and the N-terminal domain of TFIIA
Genes & Dev., May 1, 2004; 18(9): 1022 - 1034.
[Abstract] [Full Text] [PDF]


Home page
Mol. Cell. Biol.Home page
S. M. Kraemer, R. T. Ranallo, R. C. Ogg, and L. A. Stargell
TFIIA Interacts with TFIID via Association with TATA-Binding Protein and TAF40
Mol. Cell. Biol., March 1, 2001; 21(5): 1737 - 1746.
[Abstract] [Full Text]